ExThera Medical Corporation

813 Heinz Avenue
Berkeley, CA 94710 USA
Click for website

Research Sector Infectious Disease

Summary Description Develops devices to counter bloodstream infections.

Management Robert S. Ward, Ph.D. - President/CEO; George G. Pitarra, Jr. - Executive Vice President; Keith McCrea, Ph.D. - Chief Technology Officer; Kathleen A. White - Vice President & Chief Operating Officer

Click here for Financial Data
Keywords: blood-borne diseases, bacteremia, sepsis, infection, Seraph, infectious disease, InfectiousDisease


Updated: Oct. 22, 2015


ExThera Medical Corporation of Berkeley, CA has developed a revolutionary biomimetic medical device that captures and removes a wide range of pathogens and disease-causing agents from circulating bloo......view more

Products / Services

The first clinical application of Seraph will be in the treatment of Staph. aureus (including MRSA) bacteremia in end-stage renal disease patients. Later, Seraph may become a treatment for other bac......view more

Technology / Differentiation

Sepsis is a broadly defined condition that results from the immune system's response to severe infection, leading to cardiovascular collapse and multiple organ failure. It is one of the top-ten causes...view more


Proof-of-concept studies of Seraph, published in peer-reviewed journals, demonstrate that pathogens and inflammatory cytokines are removed in high-yield from human blood. First in Man clinical trial i...view more